Efficacy of a prepared tissue culture-adapted vaccine against Chlamydia psittaci experimentally in mice

Background and Aim: Chlamydia psittaci is an intracellular pathogen with a broad range of hosts and endemic in nearly all bird species as well as many mammalian species. Outbreaks contribute to economic losses, especially due to infection of pet birds, poultry, and livestock. Worse, the organism has a zoonotic effect, and transmission to humans results in severe illness. Therefore, proper control measures need to be applied. We conducted a trial for the preparation and evaluation of inactivated vaccine against C. psittaci. Materials and Methods: Three C. psittaci strains (accession nos.: KP942827, KP942828, and KP942829) were grown in embryonated chicken eggs and then propagated for purification in Vero cells. The immunization experiment was experimentally performed in mice, which then were challenged with a virulent C. psittaci strain. Results: The immunization trial revealed nearly 100% protection after the challenge. The histopathological and immunofluorescence examinations of internal organs revealed that the prepared killed vaccines can effectively reduce chlamydial infection and shedding in animals with the proper level of protection. Conclusion: Our vaccine can be used to control economic and financial losses resulting from avian chlamydiosis, especially those in poultry industries. The zoonotic transmission risk highlights the need for proper control measures.

[1]  Jian Yu,et al.  Evaluation of a tandem Chlamydia psittaci Pgp3 multiepitope peptide vaccine against a pulmonary chlamydial challenge in mice. , 2020, Microbial pathogenesis.

[2]  R. Brunham,et al.  Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine. , 2020, Vaccine.

[3]  Gilbert GREUB,et al.  Eukaryotic Cell Permeabilisation to Identify New Putative Chlamydial Type III Secretion System Effectors Secreted within Host Cell Cytoplasm , 2020, Microorganisms.

[4]  K. Weston,et al.  Recent history of psittacosis in Australia: expanding our understanding of the epidemiology of this important globally distributed zoonotic disease , 2020, Internal medicine journal.

[5]  C. Poh,et al.  Recent advances in delivery of veterinary DNA vaccines against avian pathogens , 2019, Veterinary Research.

[6]  P. Timms,et al.  Seventy Years of Chlamydia Vaccine Research – Limitations of the Past and Directions for the Future , 2019, Front. Microbiol..

[7]  C. Black,et al.  Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles , 2018, Expert review of vaccines.

[8]  L. Hogerwerf,et al.  Chlamydia psittaci (psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysis , 2017, Epidemiology and Infection.

[9]  C. Kaushic,et al.  Considerations for the rational design of a Chlamydia vaccine , 2016, Human vaccines & immunotherapeutics.

[10]  M. Knittler,et al.  Chlamydia–host cell interaction not only from a bird's eye view: some lessons from Chlamydia psittaci , 2016, FEBS letters.

[11]  S. Hasson,et al.  The past, current and future trends in DNA vaccine immunisations , 2015 .

[12]  M. Rothe,et al.  Evaluation of antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection: tetracycline versus tetracycline plus rifampicin. , 2014, Pathogens and disease.

[13]  J. El-Jakee,et al.  Chlamydia species in free-living Cattle Egret (Bubulcus ibis) and Hoopoe (Upupa epops) in Egypt , 2014 .

[14]  P. Bavoil,et al.  Genomic Analysis of an Attenuated Chlamydia abortus Live Vaccine Strain Reveals Defects in Central Metabolism and Surface Proteins , 2009, Infection and Immunity.

[15]  T. Harkinezhad,et al.  Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences. , 2009, Veterinary microbiology.

[16]  Gwendolyn R. Goss,et al.  Theory and Practice of Histological Techniques , 2009 .

[17]  P. Pastoret,et al.  Current Status of Veterinary Vaccines , 2007, Clinical Microbiology Reviews.

[18]  M. Livingstone,et al.  Vaccination against chlamydial infections of man and animals. , 2006, Veterinary journal.

[19]  S. Billington.  Clinical and zoonotic aspects of psittacosis , 2005, In Practice.

[20]  M. Del Río,et al.  Efficacy of different commercial and new inactivated vaccines against ovine enzootic abortion. , 2004, Veterinary microbiology.

[21]  M. R. Caro,et al.  Relationship between the immune response and protection conferred by new designed inactivated vaccines against ovine enzootic abortion in a mouse model. , 2003, Vaccine.

[22]  Swastik Agrawal,et al.  Evaluation of abnormal liver function tests , 2003, Postgraduate medical journal.

[23]  D. Buxton,et al.  Ovine chlamydial abortion: characterization of the inflammatory immune response in placental tissues. , 2002, Journal of comparative pathology.

[24]  D. Hostetler,et al.  Passive transfer of colostral immunoglobulins in calves. , 2000, Journal of veterinary internal medicine.

[25]  A. Stagg,et al.  Vaccines against Chlamydia: approaches and progress. , 1998, Molecular medicine today.

[26]  G. E. Jones,et al.  Intestinal Chlamydia in Finishing Pigs , 1996, Veterinary pathology.

[27]  A. Andersen,et al.  Serotyping of Chlamydia psittaci isolates using serovar-specific monoclonal antibodies with the microimmunofluorescence test , 1991, Journal of clinical microbiology.

[28]  R. Rank,et al.  Immunization against chlamydial genital infection in guinea pigs with UV-inactivated and viable chlamydiae administered by different routes , 1990, Infection and immunity.

[29]  J. Storz,et al.  Antigenic diversity of Chlamydia psittaci of mammalian origin determined by microimmunofluorescence , 1985, Infection and immunity.

[30]  D. G. Waldhalm,et al.  Efficacy of a bacterin prepared from Chlamydia psittaci grown in cell culture for experimental immunization of ewes. , 1982, Veterinary microbiology.

[31]  L. Reed,et al.  A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .

[32]  R. Hauck,et al.  Zoonoses with Public Health Relevance in Poultry , 2015 .

[33]  S. Lagae.  Chlamydia psittaci : epidemiology, zoonosis and examination of the innate immunity , 2015 .

[34]  K. Sachse,et al.  Enzootic abortion of ewes (ovine chlamydiosis) , 2012 .

[35]  Mohamed A. Enany,et al.  Investigations on the prevalence of chlamydiosis in turkey flocks in Egypt with special emphasis on immunopathological characterization of Chlamydophila psittaci. , 2009 .

[36]  J. Childs,et al.  Emerging zoonoses. , 1998, Emerging infectious diseases.

[37]  P. Payment,et al.  Methods and techniques in virology , 1993 .

[38]  D. F. Giménez.  STAINING RICKETTSIAE IN YOLK-SAC CULTURES. , 1964, Stain technology.